LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: Arctigenin alleviates cadmium-induced nephrotoxicity: Targeting endoplasmic reticulum stress, Nrf2 signaling, and the associated inflammatory response.

    Salama, Samir A / Mohamadin, Ahmed M / Abdel-Bakky, Mohamed S

    Life sciences

    2021  Volume 287, Page(s) 120121

    Abstract: Aim: Nephrotoxicity is a critical consequence of cadmium toxicity. Cadmium induces nephrotoxicity through disruption of cellular redox balance and induction of endoplasmic reticulum stress (ERS) and inflammatory responses. The present study investigated ...

    Abstract Aim: Nephrotoxicity is a critical consequence of cadmium toxicity. Cadmium induces nephrotoxicity through disruption of cellular redox balance and induction of endoplasmic reticulum stress (ERS) and inflammatory responses. The present study investigated the renoprotective effects of the naturally occurring arctigenin against the cadmium-induced nephrotoxicity.
    Main methods: Male Wistar rats were randomized into normal control, arctigenin control, cadmium, and cadmium/arctigenin groups. Cadmium and arctigenin were administered daily over a seven-day period. On the eighth day, blood and kidney tissue specimens were collected and subjected to spectrophotometric, ELISA, and immunoblotting analysis.
    Key findings: Arctigenin significantly improved renal functions and reduced renal tubular injury in the cadmium-intoxicated rats as reflected by increased GFR and reduced levels of serum creatinine, BUN, urinary albumin-to-creatinine ratio, and protein expression of KIM-1. Arctigenin alleviated the cadmium-induced oxidative DNA damage and lipid peroxidation while boosted reduced glutathione level and antioxidant enzymes activity. Mechanistically, arctigenin enhanced nuclear translocation of the antioxidant transcription factor Nrf2 and up-regulated its downstream redox-regulating enzymes HO-1 and NQO1. Importantly, arctigenin ameliorated the cadmium-evoked ERS as demonstrated by reduced protein expression of the key molecules Bip, PERK, IRE1α, CHOP, phspho-eIF2α, and caspase-12 and diminished activity of caspase-12. Additionally, arctigenin down-regulated the cadmium-induced NF-κB nuclear translocation and decreased its downstream pro-inflammatory cytokines TNF-α and IL-1β.
    Significance: The current work underlines the alleviating activity of arctigenin against cadmium-evoked nephrotoxicity potentially through mitigating ERS and targeting Nrf2 and NF-κB signaling. The current findings support possible therapeutic application of arctigenin in controlling cadmium-induced nephrotoxicity although clinical investigations are necessary.
    MeSH term(s) Animals ; Cadmium/toxicity ; Endoplasmic Reticulum Stress/drug effects ; Endoplasmic Reticulum Stress/physiology ; Furans/pharmacology ; Furans/therapeutic use ; Inflammation Mediators/antagonists & inhibitors ; Inflammation Mediators/metabolism ; Kidney Diseases/chemically induced ; Kidney Diseases/drug therapy ; Kidney Diseases/metabolism ; Lignans/pharmacology ; Lignans/therapeutic use ; Male ; NF-E2-Related Factor 2/antagonists & inhibitors ; NF-E2-Related Factor 2/metabolism ; Rats, Wistar ; Rats
    Chemical Substances Furans ; Inflammation Mediators ; Lignans ; NF-E2-Related Factor 2 ; Nfe2l2 protein, rat ; Cadmium (00BH33GNGH) ; arctigenin (U76MR9VS6M)
    Language English
    Publishing date 2021-11-04
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.120121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Arctigenin alleviates cadmium-induced nephrotoxicity: Targeting endoplasmic reticulum stress, Nrf2 signaling, and the associated inflammatory response

    Salama, Samir A. / Mohamadin, Ahmed M. / Abdel-Bakky, Mohamed S.

    Life sciences. 2021 Dec. 15, v. 287

    2021  

    Abstract: Nephrotoxicity is a critical consequence of cadmium toxicity. Cadmium induces nephrotoxicity through disruption of cellular redox balance and induction of endoplasmic reticulum stress (ERS) and inflammatory responses. The present study investigated the ... ...

    Abstract Nephrotoxicity is a critical consequence of cadmium toxicity. Cadmium induces nephrotoxicity through disruption of cellular redox balance and induction of endoplasmic reticulum stress (ERS) and inflammatory responses. The present study investigated the renoprotective effects of the naturally occurring arctigenin against the cadmium-induced nephrotoxicity.Male Wistar rats were randomized into normal control, arctigenin control, cadmium, and cadmium/arctigenin groups. Cadmium and arctigenin were administered daily over a seven-day period. On the eighth day, blood and kidney tissue specimens were collected and subjected to spectrophotometric, ELISA, and immunoblotting analysis.Arctigenin significantly improved renal functions and reduced renal tubular injury in the cadmium-intoxicated rats as reflected by increased GFR and reduced levels of serum creatinine, BUN, urinary albumin-to-creatinine ratio, and protein expression of KIM-1. Arctigenin alleviated the cadmium-induced oxidative DNA damage and lipid peroxidation while boosted reduced glutathione level and antioxidant enzymes activity. Mechanistically, arctigenin enhanced nuclear translocation of the antioxidant transcription factor Nrf2 and up-regulated its downstream redox-regulating enzymes HO-1 and NQO1. Importantly, arctigenin ameliorated the cadmium-evoked ERS as demonstrated by reduced protein expression of the key molecules Bip, PERK, IRE1α, CHOP, phspho-eIF2α, and caspase-12 and diminished activity of caspase-12. Additionally, arctigenin down-regulated the cadmium-induced NF-κB nuclear translocation and decreased its downstream pro-inflammatory cytokines TNF-α and IL-1β.The current work underlines the alleviating activity of arctigenin against cadmium-evoked nephrotoxicity potentially through mitigating ERS and targeting Nrf2 and NF-κB signaling. The current findings support possible therapeutic application of arctigenin in controlling cadmium-induced nephrotoxicity although clinical investigations are necessary.
    Keywords DNA damage ; blood serum ; cadmium ; caspase-12 ; creatinine ; endoplasmic reticulum stress ; glutathione ; immunoblotting ; inflammation ; kidneys ; lipid peroxidation ; nephrotoxicity ; protein synthesis ; therapeutics
    Language English
    Dates of publication 2021-1215
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.120121
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-κB, and apoptotic signaling and inhibiting γ-glutamyl transpeptidase.

    Salama, Samir A / Abd-Allah, Gamil M / Mohamadin, Ahmed M / Elshafey, Mostafa M / Gad, Hesham S

    Life sciences

    2021  Volume 278, Page(s) 119572

    Abstract: Aim: Cisplatin is a potent chemotherapeutic agent whose therapeutic application is hindered by the associated nephrotoxicity. Cisplatin-evoked nephrotoxicity has been largely attributed to the induction of oxidative stress and inflammatory responses. ... ...

    Abstract Aim: Cisplatin is a potent chemotherapeutic agent whose therapeutic application is hindered by the associated nephrotoxicity. Cisplatin-evoked nephrotoxicity has been largely attributed to the induction of oxidative stress and inflammatory responses. The current study aimed at investigating the ability of ergothioneine to mitigate cisplatin-evoked nephrotoxicity and to elucidate the underlining molecular mechanisms.
    Main methods: Wistar rats were treated with a daily dose of ergothioneine (70 mg/kg, po) for fourteen days and a single dose of cisplatin (5 mg/kg, ip) on day ten. On day fifteen, kidneys and blood specimens were collected and subjected to Western blotting, ELISA, histopathological, and spectrophotometric analysis.
    Key findings: Ergothioneine significantly enhanced renal function in cisplatin-treated rats as manifested by increased GFR and decreased serum creatinine and blood urea nitrogen. Ergothioneine effectively reduced the cisplatin-induced oxidative stress and mitigated apoptosis and the histopathological changes. Mechanistically, ergothioneine induced the expression of the antioxidant transcription factor Nrf2 and up-regulated its downstream targets NQO1 and HO-1. Equally important, ergothioneine inhibited γ-glutamyl transpeptidase that plays crucial roles in biotransformation of cisplatin into a toxic metabolite. Additionally, it reduced the pro-apoptotic protein p53 and the inflammatory transcription factor NF-κB along with its downstream pro-inflammatory cytokines TNF-α and IL-1β.
    Significance: The results of the current work shed the light on the ameliorating effect of ergothioneine on cisplatin-evoked nephrotoxicity that is potentially mediated through modulation of Nrf2, p53, and NF-κB signaling and inhibition of γ-glutamyl transpeptidase. This findings support the potential application of ergothioneine in controlling cisplatin-associated nephrotoxicity although clinical investigations are warranted.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Antioxidants/pharmacology ; Apoptosis ; Caspase 3/metabolism ; Cisplatin/pharmacology ; DNA Fragmentation ; Ergothioneine/pharmacology ; Kidney/drug effects ; Male ; NF-E2-Related Factor 2/metabolism ; NF-kappa B/metabolism ; Oxidative Stress ; Rats ; Rats, Wistar ; Signal Transduction ; Tumor Suppressor Protein p53/metabolism ; Up-Regulation ; gamma-Glutamyltransferase/antagonists & inhibitors ; gamma-Glutamyltransferase/metabolism
    Chemical Substances Antineoplastic Agents ; Antioxidants ; NF-E2-Related Factor 2 ; NF-kappa B ; Nfe2l2 protein, rat ; Tp53 protein, rat ; Tumor Suppressor Protein p53 ; Ergothioneine (BDZ3DQM98W) ; gamma-Glutamyltransferase (EC 2.3.2.2) ; Caspase 3 (EC 3.4.22.-) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2021-05-06
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.119572
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-κB, and apoptotic signaling and inhibiting γ-glutamyl transpeptidase

    Salama, Samir A / Abd-Allah, Gamil M / Mohamadin, Ahmed M / Elshafey, Mostafa M / Gad, Hesham S

    Life sciences. 2021 Aug. 01, v. 278

    2021  

    Abstract: Cisplatin is a potent chemotherapeutic agent whose therapeutic application is hindered by the associated nephrotoxicity. Cisplatin-evoked nephrotoxicity has been largely attributed to the induction of oxidative stress and inflammatory responses. The ... ...

    Abstract Cisplatin is a potent chemotherapeutic agent whose therapeutic application is hindered by the associated nephrotoxicity. Cisplatin-evoked nephrotoxicity has been largely attributed to the induction of oxidative stress and inflammatory responses. The current study aimed at investigating the ability of ergothioneine to mitigate cisplatin-evoked nephrotoxicity and to elucidate the underlining molecular mechanisms.Wistar rats were treated with a daily dose of ergothioneine (70 mg/kg, po) for fourteen days and a single dose of cisplatin (5 mg/kg, ip) on day ten. On day fifteen, kidneys and blood specimens were collected and subjected to Western blotting, ELISA, histopathological, and spectrophotometric analysis.Ergothioneine significantly enhanced renal function in cisplatin-treated rats as manifested by increased GFR and decreased serum creatinine and blood urea nitrogen. Ergothioneine effectively reduced the cisplatin-induced oxidative stress and mitigated apoptosis and the histopathological changes. Mechanistically, ergothioneine induced the expression of the antioxidant transcription factor Nrf2 and up-regulated its downstream targets NQO1 and HO-1. Equally important, ergothioneine inhibited γ-glutamyl transpeptidase that plays crucial roles in biotransformation of cisplatin into a toxic metabolite. Additionally, it reduced the pro-apoptotic protein p53 and the inflammatory transcription factor NF-κB along with its downstream pro-inflammatory cytokines TNF-α and IL-1β.The results of the current work shed the light on the ameliorating effect of ergothioneine on cisplatin-evoked nephrotoxicity that is potentially mediated through modulation of Nrf2, p53, and NF-κB signaling and inhibition of γ-glutamyl transpeptidase. This findings support the potential application of ergothioneine in controlling cisplatin-associated nephrotoxicity although clinical investigations are warranted.
    Keywords antioxidants ; apoptosis ; biotransformation ; blood serum ; cisplatin ; creatinine ; drug therapy ; histopathology ; metabolites ; nephrotoxicity ; oxidative stress ; pro-apoptotic proteins ; renal function ; urea nitrogen
    Language English
    Dates of publication 2021-0801
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.119572
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses.

    El-Mahdy, Hesham A / Mohamadin, Ahmed M / Abulsoud, Ahmed I / Khidr, Emad Gamil / El-Husseiny, Ahmed A / Ismail, Ahmed / Elsakka, Elsayed G E / Mokhlis, Hamada Ahmed / El-Husseiny, Hussein M / Doghish, Ahmed S

    Pathology, research and practice

    2023  Volume 245, Page(s) 154457

    Abstract: Head and neck cancers (HNCs) are a group of heterogeneous tumors formed most frequently from epithelial cells of the larynx, lips, oropharynx, nasopharynx, and mouth. Numerous epigenetic components, including miRNAs, have been demonstrated to have an ... ...

    Abstract Head and neck cancers (HNCs) are a group of heterogeneous tumors formed most frequently from epithelial cells of the larynx, lips, oropharynx, nasopharynx, and mouth. Numerous epigenetic components, including miRNAs, have been demonstrated to have an impact on HNCs characteristics like progression, angiogenesis, initiation, and resistance to therapeutic interventions. The miRNAs may control the production of numerous genes linked to HNCs pathogenesis. The roles that miRNAs play in angiogenesis, invasion, metastasis, cell cycle, proliferation, and apoptosis are responsible for this impact. The miRNAs also have an impact on crucial HNCs-related mechanistic networks like the WNT/β-catenin signaling, PTEN/Akt/mTOR pathway, TGFβ, and KRAS mutations. miRNAs may affect how the HNCs respond to treatments like radiation and chemotherapy in addition to pathophysiology. This review aims to demonstrate the relationship between miRNAs and HNCs with a particular emphasis on how miRNAs impact HNCs signaling networks.
    MeSH term(s) Humans ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Wnt Signaling Pathway ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/therapy ; Gene Expression Regulation, Neoplastic ; Cell Proliferation/genetics
    Chemical Substances MicroRNAs
    Language English
    Publishing date 2023-04-10
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 391889-0
    ISSN 1618-0631 ; 0344-0338
    ISSN (online) 1618-0631
    ISSN 0344-0338
    DOI 10.1016/j.prp.2023.154457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Corrigendum to "Protective Effects of Simvastatin, a Lipid Lowering Agent, Against Oxidative Damage in Experimental Diabetic Rats".

    Mohamadin, Ahmed M / Elberry, Ahmed A / Abdel Gawad, Hala S / Morsy, Gehan M / Al-Abbasi, Fahad A

    Journal of lipids

    2020  Volume 2020, Page(s) 4536827

    Abstract: This corrects the article DOI: 10.1155/2011/167958.]. ...

    Abstract [This corrects the article DOI: 10.1155/2011/167958.].
    Language English
    Publishing date 2020-12-16
    Publishing country Egypt
    Document type Published Erratum
    ZDB-ID 2582309-7
    ISSN 2090-3049 ; 2090-3030
    ISSN (online) 2090-3049
    ISSN 2090-3030
    DOI 10.1155/2020/4536827
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome.

    Mohamadin, Ahmed M / Habib, Fawzia A / Elahi, Thoraya Fadul

    Pathophysiology : the official journal of the International Society for Pathophysiology

    2010  Volume 17, Issue 3, Page(s) 189–196

    Abstract: Oxidative stress is considered to be implicated in the pathophysiology of polycystic ovary syndrome (PCOS). This study was designed to evaluate the paraoxonase 1 (PON1) activity and oxidant/antioxidant status in Saudi women with PCOS and its contribution ...

    Abstract Oxidative stress is considered to be implicated in the pathophysiology of polycystic ovary syndrome (PCOS). This study was designed to evaluate the paraoxonase 1 (PON1) activity and oxidant/antioxidant status in Saudi women with PCOS and its contribution to the risk of atherosclerosis. Lipid profile, hormonal parameters, serum PON1 activity and oxidant (malondialdehyde)/antioxidant (total antioxidant capacity (TAC) levels were analyzed in 35 patients with PCOS and 30 healthy controls using a spectrophotometric method; correlation analysis was made between these variables. Insulin resistance was calculated by homeostasis model assessment (HOMA-IR). Women with PCOS had significantly higher fasting insulin, HOMA-IR and LH levels than controls. Lipid profiles and free androgen index (FAI) were significantly higher in women with PCOS when compared with controls. Serum PON1 activity was lower in the PCOS group (161.2+/-6.1U/l vs. 217.6+/-9.3U/l, p<0.001) compared with controls, whereas malondialdehyde levels were higher in the PCOS group (4.26+/-0.18nmol/ml vs. 1.37+/-0.12nmol/ml, p<0.001) compared with controls. Total antioxidant capacity was lower in the PCOS group (0.88+/-0.10mmolTrolox/l vs. 1.63+/-0.17mmolTrolox/l, p<0.001) compared with controls. In PCOS group, serum PON1 was positively correlated with HDL-C (r=0.425, p<0.05) and TAC (r=0.582, p<0.01) but inversely correlated with HOMA-R (r=-0.54, p<0.01), testosterone (r=-0.672, p<0.01), FAI (r=-0.546, p<0.01) and malondialdehyde (r=-0.610, p<0.01). In conclusion, our data indicate that PON1 activity and antioxidant status were significantly decreased in Saudi women with PCOS. Lower serum PON1 activity might contribute to the increased susceptibility for the development of atherosclerosis risk in Saudi women with PCOS. Therefore, measurement of serum PON1 activity may be of value in assessment of women at higher risk for development of atherosclerosis risk in PCOS. However, further studies with larger sample size are needed to verify these results, and to assess the efficacy of antioxidant therapy on these patients.
    Language English
    Publishing date 2010-01-21
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1212740-1
    ISSN 0928-4680
    ISSN 0928-4680
    DOI 10.1016/j.pathophys.2009.11.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Serum Levels of Some Micronutrients and Congenital Malformations: A Prospective Cohort Study in Healthy Saudi-Arabian First-Trimester Pregnant Women

    Hammouda, Sahar A. Ibrahim / Abd Al-Halim, Om Alsaad Farouk / Mohamadin, Ahmed M

    International journal for vitamin and nutrition research. 2013 Dec. 1, v. 83, no. 6

    2013  

    Abstract: Background/Objectives: Various studies have linked vitamin deficiencies in early pregnancy with birth defects. The objective of this study was to identify the relationship between micronutrient deficiency and congenital malformations (CM). Subjects and ... ...

    Abstract Background/Objectives: Various studies have linked vitamin deficiencies in early pregnancy with birth defects. The objective of this study was to identify the relationship between micronutrient deficiency and congenital malformations (CM). Subjects and Methods: There were 1,180 healthy, first-trimester pregnant Saudi-Arabian females selected from the antenatal care clinics of two hospitals and 21 health care centers located all over the city. Their full medical history, clinical examination, anthropometry, and various laboratory analyses were completed. Results: Forty-eight infants were born with CM. The serum concentrations of the analyzed nutrients (selenium, zinc, magnesium, and vitamins A, E, B12, and folic acid) were significantly lower in mothers of infants with CM compared to the mothers of infants without CM. In comparison, the serum totals of homocysteine (tHcy) levels were significantly higher among the CM group. Conclusion: This study highlights the association of CM with the deficiency of certain vitamins and minerals among pregnant women.
    Keywords anthropometric measurements ; blood serum ; clinical examination ; cohort studies ; congenital abnormalities ; females ; folic acid ; homocysteine ; hospitals ; infants ; magnesium ; medical history ; minerals ; mothers ; nutrients ; pregnancy ; pregnant women ; prenatal care ; selenium ; vitamin A ; vitamin deficiencies ; zinc
    Language English
    Dates of publication 2013-1201
    Size p. 346-354.
    Publishing place Verlag Hans Huber
    Document type Article
    ZDB-ID 120692-8
    ISSN 0300-9831
    ISSN 0300-9831
    DOI 10.1024%2F0300-9831%2Fa000176
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article: Serum levels of some micronutrients and congenital malformations: a prospective cohort study in healthy saudi-arabian first-trimester pregnant women.

    Hammouda, Sahar A Ibrahim / Abd Al-Halim, Om Alsaad Farouk / Mohamadin, Ahmed M

    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

    2013  Volume 83, Issue 6, Page(s) 346–354

    Abstract: Background/objectives: Various studies have linked vitamin deficiencies in early pregnancy with birth defects. The objective of this study was to identify the relationship between micronutrient deficiency and congenital malformations (CM).: Subjects ... ...

    Abstract Background/objectives: Various studies have linked vitamin deficiencies in early pregnancy with birth defects. The objective of this study was to identify the relationship between micronutrient deficiency and congenital malformations (CM).
    Subjects and methods: There were 1,180 healthy, first-trimester pregnant Saudi-Arabian females selected from the antenatal care clinics of two hospitals and 21 health care centers located all over the city. Their full medical history, clinical examination, anthropometry, and various laboratory analyses were completed.
    Results: Forty-eight infants were born with CM. The serum concentrations of the analyzed nutrients (selenium, zinc, magnesium, and vitamins A, E, B12, and folic acid) were significantly lower in mothers of infants with CM compared to the mothers of infants without CM. In comparison, the serum totals of homocysteine (tHcy) levels were significantly higher among the CM group.
    Conclusion: This study highlights the association of CM with the deficiency of certain vitamins and minerals among pregnant women.
    MeSH term(s) Adolescent ; Adult ; Cohort Studies ; Congenital Abnormalities/blood ; Female ; Folic Acid/blood ; Humans ; Magnesium/blood ; Micronutrients/blood ; Micronutrients/deficiency ; Middle Aged ; Pregnancy ; Prospective Studies ; Saudi Arabia ; Selenium/blood ; Vitamin A/blood ; Vitamin B 12/blood ; Vitamin E/blood ; Zinc/blood
    Chemical Substances Micronutrients ; Vitamin A (11103-57-4) ; Vitamin E (1406-18-4) ; Folic Acid (935E97BOY8) ; Selenium (H6241UJ22B) ; Magnesium (I38ZP9992A) ; Zinc (J41CSQ7QDS) ; Vitamin B 12 (P6YC3EG204)
    Language English
    Publishing date 2013
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120692-8
    ISSN 0300-9831
    ISSN 0300-9831
    DOI 10.1024/0300-9831/a000176
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.

    Mohamadin, Ahmed M / Habib, Fawzia A / Al-Saggaf, Abdulrahman A

    Annals of Saudi medicine

    2010  Volume 30, Issue 4, Page(s) 278–283

    Abstract: Background and objectives: Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Little is known about cardiovascular risk factors in patients with PCOS. We investigated plasma ... ...

    Abstract Background and objectives: Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Little is known about cardiovascular risk factors in patients with PCOS. We investigated plasma markers of cardiovascular disease in Saudi women with PCOS, with an emphasis on asymmetric dimethylarginine (ADMA) and total homocysteine (tHcy).
    Patients and methods: Fifty Saudi women with PCOS diagnosed by the Rotterdam criteria (mean age [SD] 30.2 [3.0] years) and 40 controls without PCOS (mean age 29.3 [2.5] years) had measyrements taken of clinical, metabolic, and hormonal parameters, including plasma ADMA, tHcy, lipoprotein (a) ([Lp(a)], and serum high sensitivity C-reactive protein (hs-CRP), nitric oxid, and fibrinogen. Insulin resistance was calculated by the homeostasis model assessment (HOMA-IR).
    Results: Women with PCOS had significantly higher fasting insulin, HOMA-IR, and luteinizing hormone (LH) levels than healthy controls (P P P CONCLUSION: Our study revealed that Saudi women with PCOS had a significantly different levels of plasma markers of cardiovascular disease compared with normal controls. Therefore, clinicians who manage women with PCOS should follow up on these markers to reduce the risk of cardiovascular disease.
    MeSH term(s) Adult ; Arginine/analogs & derivatives ; Arginine/blood ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/etiology ; Case-Control Studies ; Female ; Homeostasis ; Homocysteine/blood ; Humans ; Insulin/blood ; Insulin Resistance ; Luteinizing Hormone/blood ; Polycystic Ovary Syndrome/complications ; Risk Factors ; Saudi Arabia/epidemiology
    Chemical Substances Insulin ; Homocysteine (0LVT1QZ0BA) ; N,N-dimethylarginine (63CV1GEK3Y) ; Luteinizing Hormone (9002-67-9) ; Arginine (94ZLA3W45F)
    Language English
    Publishing date 2010-07-11
    Publishing country Saudi Arabia
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639014-6
    ISSN 0975-4466 ; 0256-4947
    ISSN (online) 0975-4466
    ISSN 0256-4947
    DOI 10.4103/0256-4947.65255
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top